In Vitro Activities of Omadacycline (PTK 0796) and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas

Antimicrob Agents Chemother. 2016 Nov 21;60(12):7502-7504. doi: 10.1128/AAC.01734-16. Print 2016 Dec.

Abstract

In vitro activities of omadacycline, a new aminomethylcycline, were determined for Mycoplasma and Ureaplasma spp. and compared with those of azithromycin, clindamycin, moxifloxacin, tetracycline, and doxycycline. All omadacycline MICs were <2 μg/ml. MIC90s were 0.063 μg/ml for Mycoplasma hominis, 0.25 μg/ml for Mycoplasma pneumoniae, and 2 μg/ml for Ureaplasma spp. Omadacycline had the lowest MIC90 among all drugs tested against M. hominis Omadacycline activity was not affected by macrolide, tetracycline, or fluoroquinolone resistance.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Azithromycin / pharmacology
  • China
  • Clindamycin / pharmacology
  • Doxycycline / pharmacology
  • Drug Resistance, Multiple, Bacterial
  • Fluoroquinolones / pharmacology
  • Humans
  • Microbial Sensitivity Tests
  • Moxifloxacin
  • Mycoplasma Infections / microbiology
  • Mycoplasma hominis / drug effects*
  • Mycoplasma hominis / growth & development
  • Mycoplasma hominis / isolation & purification
  • Mycoplasma pneumoniae / drug effects*
  • Mycoplasma pneumoniae / growth & development
  • Mycoplasma pneumoniae / isolation & purification
  • Tetracycline / pharmacology
  • Tetracyclines / pharmacology*
  • United States

Substances

  • Anti-Bacterial Agents
  • Fluoroquinolones
  • Tetracyclines
  • omadacycline
  • Clindamycin
  • Azithromycin
  • Tetracycline
  • Doxycycline
  • Moxifloxacin